RT Journal Article
T1 Burden of First Osteoporotic Hip Fracture in Spain: A Prospective, 12-Month, Observational Study.
A1 Caeiro, Jose Ramón
A1 Bartra, Agustí
A1 Mesa-Ramos, Manuel
A1 Etxebarría, Íñigo
A1 Montejo, Jorge
A1 Carpintero, Pedro
A1 Sorio, Francesc
A1 Gatell, Sonia
A1 Farré, Andrea
A1 Canals, Laura
A1 PROA investigators, 
K1 Autonomy
K1 Cost
K1 Hip fracture
K1 Osteoporosis
K1 Quality of life
AB The purpose of this study was to estimate the burden of osteoporotic fractures beyond the hospitalization period covering up to the first year after the fracture. This was a prospective, 12-month, observational study including patients aged ≥65 years hospitalized due to a first low-trauma hip fracture, in six Spanish regions. Health resource utilization (HRU), quality of life (QoL) and autonomy were collected and total costs calculated. Four hundred and eighty seven patients (mean ± SD age 83 ± 7 years, 77 % women) were included. Twenty-two percent of patients reported a prior non-hip low-trauma fracture, 16 % were receiving osteoporotic treatment at baseline, and 3 % had densitometry performed (1.8 % T-score ≤-2.5). Sixteen percent of patients died (women 14 %; men 25 %; p = 0.0011) during the first year. Mean hospital stay was 11.8 ± 7.9 days and 95.1 % of patients underwent surgery. Other relevant HRUs were: outpatient visits in 78 % of patients (mean 9.2 ± 9.7); walking aids, 58.7 %; rehabilitation facilities, 35.5 % (28.7 ± 41.2 sessions); and formal and informal home care, 22.2 % (49.6 ± 72.2 days) and 53.4 % (77.1 ± 101.0 h), respectively. Mean direct cost was €9690 (95 % confidence interval: 9184-10,197) in women and €9019 (8079-9958) in men. Main cost drivers were: first hospitalization episode (women €7067 [73 %]; men €7196 [80 %]); outpatient visits (€1323 [14 %]; €997 [11 %]); and home care (€905 [9 %]; €767 [9 %]). QoL and autonomy showed a marked decrease during hospitalization, not entirely recovered at 12 months (p 
YR 2016
FD 2016-10-14
LK http://hdl.handle.net/10668/10534
UL http://hdl.handle.net/10668/10534
LA en
DS RISalud
RD Apr 4, 2025